Search Results 1461-1470 of 16811 for gluten intolerance

1. Publications - Lydia W. Ng, M.D. - Mayo Clinic

   Hsieh SS, Ng LW, Cao M, Lee P. A simulated comparison of lung tumor target verification using stereoscopic tomosynthesis or radiography. Med Phys.

2. Publications - Cheryl L. Willman, M.D. - Mayo Clinic

   Chang TC, Chen W, Qu C, Cheng Z, Hedges D, Elsayed A, Pounds SB, Shago M, Rabin KR, Raetz EA, Devidas M, Cheng C, Angiolillo A, Baviskar P, Borowitz M, ...

3. FAQ - eMERGE Genome Informed Risk Assessment - Mayo Clinic Research

   Do polygenic risk scores have sensitivity, specificity, or positive and negative predictive values? Although the eMERGE study team sees polygenic risk ...

4. An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer - Mayo Clinic

   Participation eligibility · Men and women, ages 18 years of age. · WOCBP must have a negative serum or urine pregnancy test (minimum sensitivity 25 IU/L or ...

5. Collaborators - Molecular Analysis of Human Diseases Laboratory - Mayo Clinic Research

   Dr. Hawse is involved in ongoing research collaborations at Mayo Clinic and other institutions. Mayo Clinic collaborators. Breast cancer. Douglas A. Collins, ...

6. Projects - Gastrointestinal Barrier Function Laboratory - Mayo Clinic Research

   Dr. Grover's Gastrointestinal Barrier Function Lab at Mayo Clinic studies irritable bowel syndrome, intestinal permeability, gastroparesis and dyspepsia.

7. Study of Orally Administered AG-120 in Subjects with Advanced Hematologic Malignancies with an IDH1 Mutation - Mayo Clinic

   2012), that is recurrent or refractory, or the subject is intolerant to established therapy known to provide clinical benefit for their condition (i.e. ...

8. Publications - Brianna E. Vaa Stelling, M.D., M.H.P.E. - Mayo Clinic

   Murad MH, Vaa Stelling BE, West CP, Hasan B, Simha S, Saadi S, Firwana M, Viola KE, Prokop LJ, Nayfeh T, Wang Z. Measuring Documentation Burden in ...

9. News - Kebede H. Begna, M.D. - Mayo Clinic

   Their crucial work saves lives every day. Let Mayo Clinic researchers know they're appreciated with a quick message.

10. AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH - Mayo Clinic

    Allergy to the study drug or its components. Receiving any investigational products within 30 days prior to Screening or anticipated use during the trial ...